» Articles » PMID: 26041666

Meta-analysis of Surgical Outcome After Enucleation Versus Standard Resection for Pancreatic Neoplasms

Overview
Journal Br J Surg
Specialty General Surgery
Date 2015 Jun 5
PMID 26041666
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pancreatic enucleation is a tissue-sparing approach to pancreatic neoplasms and may result in better postoperative pancreatic function than standard pancreatic resection. The objective of this review was to compare the postoperative outcome after pancreatic enucleation versus standard resection.

Methods: MEDLINE, Embase and the Cochrane Library were searched systematically until February 2015 to identify studies comparing the outcome of enucleation versus standard resection for pancreatic neoplasms. After critical appraisal, meta-analysis was performed and the findings were presented as odds ratios or weighted mean differences with corresponding 95 per cent c.i.

Results: Twenty-two observational studies (1148 patients) were included. Duration of surgery (P < 0.001), blood loss (P < 0.001), length of hospital stay (P = 0.04), and postoperative endocrine (P < 0.001) and exocrine (P = 0.01) insufficiency were lower after enucleation than after standard resection. Mortality (P = 0.44), overall complications (P = 0.74), reoperation rate (P = 0.93) and delayed gastric emptying (P = 0.15) were not significantly different between the two approaches. The overall rate of postoperative pancreatic fistula (POPF) was higher after enucleation than after standard resection (P < 0.001). However, the raised POPF rate did not result in higher mortality or overall morbidity. Sensitivity analysis of high-volume studies (total of more than 20 enucleations and more than 4 per year) showed that, in specialized centres, enucleation can be performed with no increased risk of POPF (P = 0.12).

Conclusion: Compared with standard resection, pancreatic enucleation can be performed effectively and with comparable safety in high-volume institutions. Enucleation should be considered instead of standard resection for selected pancreatic neoplasms.

Citing Articles

Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours.

Ritter A, Poppinga J, Steinkraus K, Hackert T, Niessen A Curr Oncol Rep. 2025; 27(2):157-167.

PMID: 39862354 PMC: 11861007. DOI: 10.1007/s11912-024-01632-4.


Laparoscopic pancreatic enucleation: how far should we go for parenchyma preservation? A study by the French National Association of Surgery.

Pastier C, de Ponthaud C, Nassar A, Soubrane O, Mazzotta A, Souche F Surg Endosc. 2025; 39(3):1696-1708.

PMID: 39806174 DOI: 10.1007/s00464-024-11453-y.


ASO Author Reflections: Preoperative Pancreatic Duct Stenting in Pancreatic Enucleation: A Clinical Insight into Reducing Postoperative Fistula Risk.

Li L, Liu Y Ann Surg Oncol. 2024; 32(3):1904-1905.

PMID: 39719515 DOI: 10.1245/s10434-024-16770-z.


Mitigating Postoperative Fistula Risks in Laparoscopic Pancreatic Enucleation: A Retrospective Study.

Li L, Li X, Liu K, Wu W, Li M, Liu Y Ann Surg Oncol. 2024; 32(3):1887-1895.

PMID: 39710806 PMC: 11811477. DOI: 10.1245/s10434-024-16702-x.


Laparoscopic Central Pancreatectomy with Modified Blumgart Pancreatojejunostomy for Pancreatic Neuroendocrine Tumor.

Constant M, Doussot A Ann Surg Oncol. 2024; 31(13):8723-8724.

PMID: 39292402 DOI: 10.1245/s10434-024-16248-y.